Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|June 20, 2025
NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor MicroenvironmentRoberta Turiello, Susanna S Ng, Elisabeth Tan, et al.
Scientific Reports|January 2, 2023
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progressionMiriam Saponaro, Sina Flottmann, Markus Eckstein, et al.
Clinical & Translational Immunology|June 6, 2022
Increased amphiregulin expression by CD4<sup>+</sup> T cells from individuals with asymptomatic <i>Leishmania donovani</i> infectionSiddharth Sankar Singh, Shashi Bhushan Chauhan, Susanna Ss Ng, et al.
European Journal of Immunology|November 12, 2024
Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in CancerDillon Corvino, Martin Batstone, Brett G M Hughes, et al.
Cancer Research|January 4, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial CarcinomaSana Hosni, Viola Kilian, Niklas Klümper, et al.
Nature Communications|May 28, 2024
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Sonia Leonardelli, et al.
JCI Insight|November 2, 2023
A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseasesChelsea L Edwards, Jessica A Engel, Fabian de Labastida Rivera, et al.
The Journal of Clinical Investigation|October 2, 2023
STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malariaYulin Wang, Fabian De Labastida Rivera, Chelsea L Edwards, et al.
The Journal of Clinical Investigation|January 3, 2023
IL-10-producing Th1 cells possess a distinct molecular signature in malariaChelsea L Edwards, Susanna S Ng, Fabian de Labastida Rivera, et al.
Cell Reports|February 27, 2020
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral LeishmaniasisRajiv Kumar, Patrick T Bunn, Siddharth Sankar Singh, et al.
Pageof 3